Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Sell
40
HBIO Quote, Financials, Valuation and Earnings
Last price:
$2.07
Seasonality move
:
6.15%
Day range:
$2.07 - $2.12
52-week range:
$1.99 - $5.56
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.93x
P/B ratio:
1.40x
Volume:
162.9K
Avg. volume:
187.2K
1-year change:
-61.11%
Market cap:
$91.6M
Revenue:
$112.3M
EPS (TTM):
-$0.33
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $116.2M | $102.1M | $118.9M | $113.3M | $112.3M | |
| Revenue Growth (YoY) | -3.81% | -12.12% | 16.46% | -4.68% | -0.96% | |
| Cost of Revenues | $51.9M | $44.1M | $51.3M | $52.5M | $46.2M | |
| Gross Profit | $64.3M | $58M | $67.7M | $60.8M | $66.1M | |
| Gross Profit Margin | 55.37% | 56.85% | 56.9% | 53.66% | 58.86% | |
| R&D Expenses | $10.7M | $8.7M | $10.8M | $12.3M | $11.8M | |
| Selling, General & Admin | $46M | $43.4M | $48.9M | $49.5M | $46.9M | |
| Other Inc / (Exp) | -$1.9M | -$2.7M | -$666K | $535K | -$859K | |
| Operating Expenses | $62.5M | $57.8M | $65.6M | $68M | $64.2M | |
| Operating Income | $1.8M | $221K | $2.1M | -$7.2M | $1.9M | |
| Net Interest Expenses | $5.4M | $4.8M | $1.5M | $2.5M | $3.6M | |
| EBT. Incl. Unusual Items | -$5.5M | -$7.3M | -$140K | -$9.2M | -$2.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$815K | $518K | $148K | $337K | $859K | |
| Net Income to Company | -$4.7M | -$7.8M | -$288K | -$9.5M | -$3.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$4.7M | -$7.8M | -$288K | -$9.5M | -$3.4M | |
| Basic EPS (Cont. Ops) | -$0.12 | -$0.20 | -$0.01 | -$0.23 | -$0.08 | |
| Diluted EPS (Cont. Ops) | -$0.12 | -$0.20 | -$0.01 | -$0.23 | -$0.08 | |
| Weighted Average Basic Share | $37.8M | $38.6M | $40.3M | $41.4M | $42.4M | |
| Weighted Average Diluted Share | $37.8M | $38.6M | $40.3M | $41.4M | $42.4M | |
| EBITDA | $7.6M | $5.2M | $9M | $944K | $8M | |
| EBIT | -$92K | -$2.5M | $1.4M | -$6.6M | $1M | |
| Revenue (Reported) | $116.2M | $102.1M | $118.9M | $113.3M | $112.3M | |
| Operating Income (Reported) | $1.8M | $221K | $2.1M | -$7.2M | $1.9M | |
| Operating Income (Adjusted) | -$92K | -$2.5M | $1.4M | -$6.6M | $1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $24M | $29.7M | $26.9M | $25.4M | $22M | |
| Revenue Growth (YoY) | -12.33% | 23.41% | -9.24% | -5.79% | -13.38% | |
| Cost of Revenues | $10.5M | $13.4M | $14.8M | $10.6M | $9.2M | |
| Gross Profit | $13.5M | $16.3M | $12.2M | $14.7M | $12.8M | |
| Gross Profit Margin | 56.14% | 54.98% | 45.21% | 58.07% | 58.1% | |
| R&D Expenses | $1.9M | $2.7M | $2.8M | $2.8M | $2.6M | |
| Selling, General & Admin | $10M | $11.6M | $12.1M | $11.5M | $10.6M | |
| Other Inc / (Exp) | -$392K | -$130K | $365K | $1.3M | -$1.9M | |
| Operating Expenses | $13.3M | $15.8M | $16.5M | $15.7M | $14.5M | |
| Operating Income | $182K | $548K | -$4.3M | -$933K | -$1.7M | |
| Net Interest Expenses | $1.2M | $373K | $749K | $882K | $856K | |
| EBT. Incl. Unusual Items | -$1.4M | $45K | -$4.7M | -$562K | -$4.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$317K | $215K | -$1.3M | $677K | $311K | |
| Net Income to Company | -$1.1M | -$170K | -$3.4M | -$1.2M | -$4.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.1M | -$170K | -$3.4M | -$1.2M | -$4.8M | |
| Basic EPS (Cont. Ops) | -$0.03 | -$0.00 | -$0.08 | -$0.03 | -$0.11 | |
| Diluted EPS (Cont. Ops) | -$0.03 | -$0.00 | -$0.08 | -$0.03 | -$0.11 | |
| Weighted Average Basic Share | $38.9M | $40.8M | $41.6M | $42.7M | $43.6M | |
| Weighted Average Diluted Share | $38.9M | $40.8M | $41.6M | $42.7M | $43.6M | |
| EBITDA | $1.6M | $2.3M | -$2M | $2.1M | -$1.8M | |
| EBIT | -$210K | $418K | -$3.9M | $320K | -$3.6M | |
| Revenue (Reported) | $24M | $29.7M | $26.9M | $25.4M | $22M | |
| Operating Income (Reported) | $182K | $548K | -$4.3M | -$933K | -$1.7M | |
| Operating Income (Adjusted) | -$210K | $418K | -$3.9M | $320K | -$3.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $102.1M | $116.8M | $118M | $112.5M | $97.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $44.5M | $51M | $53.4M | $46.9M | $40.7M | |
| Gross Profit | $57.6M | $65.8M | $64.5M | $65.6M | $57.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $9M | $10.2M | $12.4M | $11.5M | $11.2M | |
| Selling, General & Admin | $43.7M | $46.6M | $51.2M | $47.2M | $45M | |
| Other Inc / (Exp) | -$786K | -$2.7M | -$119K | $197K | -$4.7M | |
| Operating Expenses | $58.4M | $62.7M | $69.6M | $64.4M | $62.6M | |
| Operating Income | -$842K | $3.1M | -$5M | $1.2M | -$5.5M | |
| Net Interest Expenses | $5M | $2.3M | $2M | $3.7M | $3.2M | |
| EBT. Incl. Unusual Items | -$6.6M | -$1.8M | -$7.2M | -$2.3M | -$13.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1K | $45K | -$267K | $918K | $883K | |
| Net Income to Company | -$6.6M | -$1.9M | -$6.9M | -$3.3M | -$14.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$6.6M | -$1.9M | -$6.9M | -$3.3M | -$14.2M | |
| Basic EPS (Cont. Ops) | -$0.31 | -$0.05 | -$0.17 | -$0.08 | -$0.33 | |
| Diluted EPS (Cont. Ops) | -$0.31 | -$0.05 | -$0.17 | -$0.08 | -$0.33 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $6M | $8.1M | $2.4M | $8.5M | -$3M | |
| EBIT | -$1.6M | $436K | -$5.1M | $1.4M | -$10.2M | |
| Revenue (Reported) | $102.1M | $116.8M | $118M | $112.5M | $97.7M | |
| Operating Income (Reported) | -$842K | $3.1M | -$5M | $1.2M | -$5.5M | |
| Operating Income (Adjusted) | -$1.6M | $436K | -$5.1M | $1.4M | -$10.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $71.1M | $85.8M | $84.9M | $84.1M | $69.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $30.8M | $37.8M | $39.9M | $34.4M | $28.8M | |
| Gross Profit | $40.3M | $48.1M | $45M | $49.7M | $40.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $6.3M | $7.8M | $9.5M | $8.6M | $8.1M | |
| Selling, General & Admin | $32.3M | $35.5M | $37.7M | $35.4M | $33.5M | |
| Other Inc / (Exp) | -$472K | -$477K | $70K | -$268K | -$4.1M | |
| Operating Expenses | $42.9M | $47.7M | $51.7M | $48.1M | $46.5M | |
| Operating Income | -$2.5M | $367K | -$6.7M | $1.6M | -$5.8M | |
| Net Interest Expenses | $3.7M | $1.2M | $1.6M | $2.8M | $2.4M | |
| EBT. Incl. Unusual Items | -$6.7M | -$1.3M | -$8.3M | -$1.5M | -$12.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $451K | -$22K | -$437K | $144K | $168K | |
| Net Income to Company | -$7.2M | -$1.2M | -$7.9M | -$1.6M | -$12.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$7.2M | -$1.2M | -$7.9M | -$1.6M | -$12.4M | |
| Basic EPS (Cont. Ops) | -$0.19 | -$0.03 | -$0.19 | -$0.04 | -$0.29 | |
| Diluted EPS (Cont. Ops) | -$0.19 | -$0.03 | -$0.19 | -$0.04 | -$0.29 | |
| Weighted Average Basic Share | $115.7M | $120.7M | $124.2M | $127.2M | $130.5M | |
| Weighted Average Diluted Share | $115.7M | $120.7M | $125.4M | $127.8M | $130.5M | |
| EBITDA | $2.7M | $5.6M | -$1M | $6.6M | -$4.5M | |
| EBIT | -$3M | -$110K | -$6.6M | $1.3M | -$9.9M | |
| Revenue (Reported) | $71.1M | $85.8M | $84.9M | $84.1M | $69.6M | |
| Operating Income (Reported) | -$2.5M | $367K | -$6.7M | $1.6M | -$5.8M | |
| Operating Income (Adjusted) | -$3M | -$110K | -$6.6M | $1.3M | -$9.9M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.3M | $8.3M | $7.8M | $4.5M | $4.3M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $20.7M | $17.8M | $21.8M | $16.7M | $16.1M | |
| Inventory | $22.1M | $22.3M | $27.6M | $26.4M | $24.7M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $2.5M | $3.4M | $4.3M | $3.5M | $3.9M | |
| Total Current Assets | $53.6M | $51.7M | $61.6M | $51.1M | $49M | |
| Property Plant And Equipment | $13.2M | $11.7M | $10.3M | $9.2M | $8.8M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $57.4M | $58.6M | $57.7M | $56.3M | $57.1M | |
| Other Intangibles | $38.4M | $33.2M | $27.4M | $21M | $16M | |
| Other Long-Term Assets | $2.3M | $1.1M | $5.4M | $7.8M | $6.5M | |
| Total Assets | $164.9M | $156.3M | $162.3M | $145.4M | $137.4M | |
| Accounts Payable | $5.3M | $6M | $4.9M | $6.4M | $5.6M | |
| Accrued Expenses | $425K | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $6.9M | $1.7M | $3.2M | $3.8M | $5.9M | |
| Current Portion Of Capital Lease Obligations | $2.4M | $2.1M | $2.1M | $2.1M | $1.4M | |
| Other Current Liabilities | $2.9M | $3.3M | $4.3M | $4M | $5.3M | |
| Total Current Liabilities | $25.3M | $21.1M | $25.3M | $23.2M | $26.5M | |
| Long-Term Debt | $46.9M | $46.3M | $45.1M | $43M | $30.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $83.2M | $79.6M | $78.9M | $73.1M | $64.3M | |
| Common Stock | $438K | $444K | $452K | $454K | $434K | |
| Other Common Equity Adj | -$12.7M | -$13.1M | -$10M | -$15.1M | -$14.2M | |
| Common Equity | $81.7M | $76.7M | $83.4M | $72.2M | $73.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $81.7M | $76.7M | $83.4M | $72.2M | $73.1M | |
| Total Liabilities and Equity | $164.9M | $156.3M | $162.3M | $145.4M | $137.4M | |
| Cash and Short Terms | $8.3M | $8.3M | $7.8M | $4.5M | $4.3M | |
| Total Debt | $53.8M | $48M | $48.3M | $46.8M | $36.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.8M | $5.5M | $5.1M | $5.3M | $4.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $13.9M | $18.3M | $15M | $15M | $12.8M | |
| Inventory | $22.7M | $26M | $26.1M | $25.8M | $26M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $4.1M | $5.8M | $5.5M | $4.3M | $3.4M | |
| Total Current Assets | $43.5M | $55.7M | $51.8M | $50.5M | $46.8M | |
| Property Plant And Equipment | $12.2M | $10.5M | $9.6M | $8.4M | $11.7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $57.6M | $58M | $54.9M | $56.2M | $57.4M | |
| Other Intangibles | $34.3M | $28.9M | $22.5M | $17.1M | $12.3M | |
| Other Long-Term Assets | $1.9M | $724K | $8.3M | $7.5M | $2.9M | |
| Total Assets | $149.6M | $153.9M | $147M | $139.7M | $131.2M | |
| Accounts Payable | $6M | $5.6M | $5.9M | $6.3M | $5.3M | |
| Accrued Expenses | $376K | $369K | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $2.8M | $2.5M | $2.7M | $3.5M | $3.6M | |
| Current Portion Of Capital Lease Obligations | $2.2M | $2.1M | $2.1M | $2.1M | $1.1M | |
| Other Current Liabilities | $3.2M | $4.8M | $3.7M | $4.7M | $6.8M | |
| Total Current Liabilities | $21.2M | $23.5M | $21.4M | $24.2M | $22.8M | |
| Long-Term Debt | $40.7M | $42.7M | $46.5M | $35.3M | $34.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $72.4M | $77M | $75M | $65.4M | $65.9M | |
| Common Stock | $438K | $451K | $453K | $457K | $436K | |
| Other Common Equity Adj | -$12M | -$15M | -$16.2M | -$15.3M | -$13.1M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $77.2M | $76.9M | $72M | $74.3M | $65.3M | |
| Total Liabilities and Equity | $149.6M | $153.9M | $147M | $139.7M | $131.2M | |
| Cash and Short Terms | $2.8M | $5.5M | $5.1M | $5.3M | $4.6M | |
| Total Debt | $43.5M | $45.2M | $49.3M | $38.7M | $37.9M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$4.7M | -$7.8M | -$288K | -$9.5M | -$3.4M | |
| Depreciation & Amoritzation | $7.7M | $7.6M | $7.6M | $7.6M | $7M | |
| Stock-Based Compensation | $3M | $3.6M | $4.2M | $4.4M | $5M | |
| Change in Accounts Receivable | $468K | $3.1M | -$4.3M | $4.8M | $810K | |
| Change in Inventories | $3.3M | $413K | -$5.9M | $252K | $1.5M | |
| Cash From Operations | $8M | $9.3M | $1.3M | $1.2M | $14M | |
| Capital Expenditures | $1.2M | $1.4M | $1.3M | $1.6M | $2.3M | |
| Cash Acquisitions | $1M | -- | -- | -- | $512K | |
| Cash From Investing | -$229K | -$1.4M | -$1.3M | -$1.6M | -$1.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $4.3M | $61.3M | $4.3M | $7.8M | $4.5M | |
| Long-Term Debt Repaid | -$11.7M | -$66.9M | -$4.2M | -$9.6M | -$15M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$221K | -$3M | -$3.6M | -$1.6M | -$2.5M | |
| Cash From Financing | -$7.6M | -$8M | -$252K | -$2.8M | -$12.1M | |
| Beginning Cash (CF) | $8.2M | $8.3M | $8.3M | $7.8M | $4.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $192K | -$38K | -$335K | -$3.3M | $95K | |
| Ending Cash (CF) | $8.3M | $8.3M | $7.8M | $4.5M | $4.3M | |
| Levered Free Cash Flow | $6.8M | $7.9M | -$83K | -$438K | $11.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$1.1M | -$170K | -$3.4M | -$1.2M | -$4.8M | |
| Depreciation & Amoritzation | $1.8M | $1.9M | $1.9M | $1.8M | $1.8M | |
| Stock-Based Compensation | $1.1M | $1M | $1.1M | $1.4M | $1.1M | |
| Change in Accounts Receivable | $950K | -$1.1M | $2.5M | $1.8M | -$155K | |
| Change in Inventories | $863K | -$1.5M | $2.3M | -$225K | -$668K | |
| Cash From Operations | $1.6M | -$660K | $649K | $4.4M | -$842K | |
| Capital Expenditures | $564K | $480K | $442K | $401K | $1.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$564K | -$480K | -$442K | -$401K | -$1.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $3.5M | $2.5M | $2.5M | $1M | $3.3M | |
| Long-Term Debt Repaid | -$3.8M | -$500K | -$1.8M | -$3.8M | -$1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$620K | -$1.7M | -$387K | -- | -$161K | |
| Cash From Financing | -$953K | $487K | $377K | -$2.8M | $2.1M | |
| Beginning Cash (CF) | $2.6M | $6.2M | $4.3M | $4.3M | $4M | |
| Foreign Exchange Rate Adjustment | $97K | -$36K | $301K | -$194K | $370K | |
| Additions / Reductions | $80K | -$653K | $584K | $1.2M | $151K | |
| Ending Cash (CF) | $2.8M | $5.5M | $5.1M | $5.3M | $4.6M | |
| Levered Free Cash Flow | $1M | -$1.1M | $207K | $4M | -$2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6.6M | -$1.9M | -$6.9M | -$3.3M | -$14.2M | |
| Depreciation & Amoritzation | $7.7M | $7.6M | $7.5M | $7.2M | $7.2M | |
| Stock-Based Compensation | $3.5M | $4.1M | $4.4M | $4.6M | $4.8M | |
| Change in Accounts Receivable | $3.5M | -$4.4M | $2.5M | $471K | $2.4M | |
| Change in Inventories | $2.1M | -$3.1M | -$2.1M | $754K | -$1.1M | |
| Cash From Operations | $9.1M | $3.6M | -$1.4M | $12.4M | $4M | |
| Capital Expenditures | $1.5M | $1.3M | $1.7M | $1.5M | $3.9M | |
| Cash Acquisitions | -$18K | -- | -- | $512K | -- | |
| Cash From Investing | -$1.5M | -$1.3M | -$1.7M | -$973K | -$1.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $54.2M | $9.6M | $3.5M | $9.8M | |
| Long-Term Debt Repaid | -$20.9M | -$52.2M | -$5.8M | -$14.3M | -$10.8M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$711K | -$4.9M | -$2M | -$912K | -$2.3M | |
| Cash From Financing | -$11.8M | $511K | $2.5M | -$10.7M | -$2.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$4.2M | $2.8M | -$636K | $683K | -$811K | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $7.5M | $2.3M | -$3.1M | $10.9M | $160K | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$7.2M | -$1.2M | -$7.9M | -$1.6M | -$12.4M | |
| Depreciation & Amoritzation | $5.7M | $5.7M | $5.6M | $5.2M | $5.4M | |
| Stock-Based Compensation | $2.6M | $3.1M | $3.4M | $3.6M | $3.4M | |
| Change in Accounts Receivable | $6.8M | -$727K | $6.1M | $1.8M | $3.3M | |
| Change in Inventories | -$511K | -$4M | -$329K | $173K | -$2.4M | |
| Cash From Operations | $6.8M | $1.1M | -$1.5M | $9.7M | -$285K | |
| Capital Expenditures | $1.1M | $987K | $1.4M | $1.3M | $2.8M | |
| Cash Acquisitions | -- | -- | -- | $512K | -- | |
| Cash From Investing | -$1.1M | -$987K | -$1.4M | -$738K | -$878K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $9.6M | $2.5M | $7.8M | $3.5M | $8.8M | |
| Long-Term Debt Repaid | -$20.3M | -$5.5M | -$7.1M | -$11.8M | -$7.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$882K | -$2.8M | -$1.2M | -$451K | -$220K | |
| Cash From Financing | -$11.3M | -$2.8M | -$107K | -$8M | $1.2M | |
| Beginning Cash (CF) | $16.8M | $20.4M | $17.5M | $12.6M | $12.6M | |
| Foreign Exchange Rate Adjustment | $42K | -$81K | $312K | -$137K | $223K | |
| Additions / Reductions | -$5.6M | -$2.7M | -$3M | $969K | $63K | |
| Ending Cash (CF) | $11.3M | $17.6M | $14.8M | $13.5M | $12.9M | |
| Levered Free Cash Flow | $5.8M | $158K | -$2.9M | $8.5M | -$3.1M | |
Get HBIO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HBIO
Sector
P/E ratio
--
25.78x
PEG ratio
-0.02x
0.00x
P/B ratio
1.40x
1.85x
Price / LTM sales
0.93x
1.86x
Growth Metrics
HBIO
Sector
Revenue growth
-13.38%
7.28%
Earnings growth
--
1.67%
Revenue (5-year growth)
-1.45%
8.73%
Earnings forecast
$0.02
-$0.20
Profitability
HBIO
Sector
Profitability FY 2023
$66.1M
$57.1M
Return on invested capital
-13.35%
-14.09%
Return on assets
-10.62%
-11.79%
Return on equity
-20.42%
-14.85%
Earnings Date
Last Earnings Date
Nov
7
Next Earnings Date
Mar
7
Estimated Next Earnings Date
Feb
6
Balance Sheet
HBIO
Sector
Total cash
$4.6M
$46.9M
Short term investments
--
$44M
Total assets
$137.4M
$142M
Long term debt
$37.9M
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 8.33% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 0.76% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is down 0.77% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
